Published in Gene Therapy Weekly, December 30th, 2004
According to a study from Italy, "Cdc7 is an evolutionarily conserved kinase that regulates S phase by promoting replication origin activation.
"Unlike replication fork blockade," wrote A. Montagnoli and colleagues, "Cdc7-depleted tumor cells do not elicit a robust checkpoint response; thus, inhibitory signals preventing additional cell cycle progression are not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.